News Releases Year None2023202220212020201920182017 Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid Mar 24, 2023 NuCana to Participate in Two Upcoming Investor Conferences Feb 28, 2023 NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement Jan 23, 2023 NuCana Announces Receipt of NASDAQ Notice Jan 06, 2023 NuCana to Host Investor Meetings During the J.P. Morgan Healthcare Conference Jan 03, 2023 NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update Nov 16, 2022 NuCana to Present at the Jefferies London Healthcare Conference Nov 08, 2022 NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022 Oct 26, 2022 NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022 Sep 12, 2022 NuCana Presents Favorable Data on NUC-3373 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022 Sep 12, 2022 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid Mar 24, 2023
NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022 Oct 26, 2022
NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022 Sep 12, 2022
NuCana Presents Favorable Data on NUC-3373 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022 Sep 12, 2022